Table 2.

Cumulative ALL mortality among 7,365 children diagnosed with ALL by diagnosis period, SEER 9 registries, 1975–2010

1975–19831984–19911992–19992000–2010
5-Year cumulative ALL mortality (95% CI)
All children0.35 (0.32–0.37)0.23 (0.21–0.26)0.16 (0.14–0.17)0.10 (0.09–0.11)
Race/ethnicity
 NH-white0.33 (0.30–0.36)0.20 (0.18–0.23)0.13 (0.11–0.15)0.08 (0.07–0.10)
 NH-black0.48 (0.38–0.58)0.43 (0.33–0.51)0.22 (0.15–0.29)0.11 (0.06–0.16)
 Hispanic0.43 (0.34–0.51)0.30 (0.23–0.37)0.22 (0.17–0.28)0.15 (0.12–0.19)
 API0.31 (0.22–0.41)0.20 (0.14–0.27)0.15 (0.10–0.21)0.10 (0.07–0.15)
 AIAN0.38 (0.15–0.61)0.41 (0.23–0.57)0.26 (0.10–0.45)0.19 (0.08–0.32)
Sex
 Girls0.30 (0.26–0.33)0.21 (0.18–0.24)0.13 (0.10–0.15)0.09 (0.07–0.11)
 Boys0.39 (0.35–0.42)0.26 (0.23–0.29)0.18 (0.15–0.20)0.11 (0.10–0.13)
Age at diagnosis, y
 <10.68 (0.53–0.79)0.63 (0.50–0.74)0.37 (0.23–0.52)0.31 (0.21–0.41)
 1–90.26 (0.24–0.29)0.15 (0.13–0.18)0.10 (0.09–0.12)0.05 (0.04–0.07)
 10–190.51 (0.47–0.56)0.42 (0.37–0.47)0.29 (0.25–0.33)0.20 (0.17–0.23)